Polycomb Complex Group Gene Mutations and Their Prognostic Relevance In 5-Azacitidine Treated Myelodysplastic Syndrome Patients

被引：0

作者：

Kulasekararaj, Austin G. ^{[1
]}

Mohamedali, Azim M. ^{[2
]}

Smith, Alexander E. ^{[2
]}

Lea, Nicholas C. ^{[2
]}

Kizilors, Aytug ^{[2
]}

Abdallah, Atiyeh ^{[1
]}

Nasser, Erik E. ^{[2
]}

Mian, Syed A. ^{[2
]}

Yiu, Richard ^{[1
]}

Gaken, Joop ^{[2
]}

Pomplun, Sabine ^{[2
]}

Jiang, Jie ^{[1
]}

Gaymes, Terry J. ^{[2
]}

Pasipanodya, Patience ^{[1
]}

Hayden, Janet ^{[1
]}

Ireland, Robin M. ^{[1
]}

Lim, ZiYi ^{[1
]}

Ho, Aloysius Y. ^{[1
]}

Marsh, Judith C. W. ^{[1
]}

Mufti, Ghulam J. ^{[2
]}

机构：

[1] Kings Coll Hosp, Dept Haematol Med, London, England

[2] Kings Coll London, Dept Haematol Med, London WC2R 2LS, England

来源：

BLOOD | 2010年 / 116卷 / 21期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：61 / 61

页数：1

共 50 条

[1] Outcome of 5-Azacitidine and Decitabine Treatment in Elderly Patients with Myelodysplastic Syndrome
Nam, Seung-Hyun
Lim, Taekyu
Kim, Bong-Seog
BLOOD, 2012, 120 (21)
[2] OUTCOME OF 5-AZACITIDINE AND DECITABINE TREATMENT IN ELDERLY PATIENTS WITH MYELODYSPLASTIC SYNDROME
Nam, S.
Lim, T.
Kim, B.
HAEMATOLOGICA, 2013, 98 : 588 - 588
[3] Leukemia cutis in myelodysplastic syndrome and chronic myelomonocytic leukemia patients treated with adjusted dose 5-azacitidine
Stefania Infante, Maria
Munoz, Carolina
Heras, Cecilia
Angeles Foncillas, Maria
Gonzalez, Isabel
Lucea, Irene
Echavarria, Eva
Aramendi, Teresa
Angel Hernandez, Jose
EUROPEAN JOURNAL OF DERMATOLOGY, 2015, 25 (06) : 622 - 623
[4] Leukemia cutis in myelodysplastic syndrome and chronic myelomonocytic leukemia patients treated with adjusted dose 5-azacitidine
María Stefania Infante
Carolina Muñoz
Cecilia Heras
María Angeles Foncillas
Isabel González
Irene Lucea
Eva Echavarria
Teresa Aramendi
José Angel Hernández
European Journal of Dermatology, 2015, 25 : 622 - 623
[5] The Prognostic Value of Monosomal Karyotype (MK) in High-Risk Patients with Myelodysplastic Syndromes Treated with 5-Azacitidine
Papageorgiou, Sotirios
Kontos, Christos K.
Tsiambalis, Thomas
Vyniou, Athina
Symeonidis, Argiris
Galanopoulos, Athanasios
Kotsianidis, Ioannis
Pappa, Vassiliki
BLOOD, 2017, 130
[6] DNA Methylation Changes Following 5-azacitidine Treatment in Patients with Myelodysplastic Syndrome
Huong Thi Thanh Tran
Kim, Hee Nam
Lee, Il-Kwon
Kim, Yeo-Kyeoung
Ahn, Jae-Sook
Yang, Deok-Hwan
Lee, Je-Jung
Kim, Hyeoung-Joon
JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (02) : 207 - 213
[7] DNA Methylation Changes Following 5-Azacitidine Treatment in Patients with Myelodysplastic Syndrome
Tran, Huong Thi Thanh
Kim, Hee Nam
Kim, Yeo-Kyeoung
Ahn, Jae-Sook
Lee, Il-Kwon
Yang, Deok-Hwan
Lee, Je-Jung
Hoon, Kook
Hwang, Tai Ju
Kim, Hyeoung-Joon
BLOOD, 2009, 114 (22) : 1091 - 1092
[8] EXPERIENCE WITH THE USE OF 5-AZACITIDINE IN PATIENTS WITH MYELODYSPLASTIC SYNDROME OF LOW/INTERMEDIATE RISK
Llorente Dunia, De Miguel
Lopez Nuria, Golbano
Morfa Miguel, Diaz
Juanis Jaime, Arbeteta
Sanz Dolores, Morales
Perez Dolores, Subira
Maqueda Cristina, Fernandez
Ramo Alejandro, Vazquez
Martin Sonia, Herrero
Albiz Blanca, Pinedo
HAEMATOLOGICA, 2016, 101 : 152 - 152
[9] Pretransplantation 5-Azacitidine in High-Risk Myelodysplastic Syndrome
Nishihori, Taiga
Perkins, Janelle
Mishra, Asmita
Komrokji, Rami
Kim, Jongphil
Kharfan-Dabaja, Mohamed A.
Perez, Lia
Lancet, Jeffrey
Fernandez, Hugo
List, Alan
Anasetti, Claudio
Field, Teresa
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (06) : 776 - 780
[10] INFECTIOUS COMPLICATIONS IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES/ACUTE MYELOID LEUKEMIA TREATED WITH 5-AZACITIDINE
Ramos, S.
Santos, M.
Tenreiro, R.
Pereira, M.
Cortesao, E.
Rito, L.
Ribeiro, M. L.
HAEMATOLOGICA, 2015, 100 : 474 - 475

← 1 2 3 4 5 →